- within Immigration, Litigation and Mediation & Arbitration topic(s)
- with Senior Company Executives, HR and Finance and Tax Executives
- with readers working within the Automotive, Basic Industries and Insurance industries
Christopher Kinkade was featured in the Law360 article "Everett can't Bar Acella from Linking Vitamins in Databases." While the full text can be found in the August 29, 2013, issue of Law360, a synopsis is noted below.
A New Jersey federal judge turned down Everett Laboratories Inc.'s requests for three injunctions prohibiting Acella Pharmaceuticals LLC from associating itself with Everett's prenatal vitamins in drug databases, saying Everett's claim wasn't valid on four individual patents wasn't inherently valid.
Christopher R. Kinkade of Fox Rothschild LLP represented Acella Pharmaceuticals LLC.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
